The use of ebselen for radioprotection in cultured cells and mice.
Ionizing radiation induces the production of reactive oxygen species (ROS), which play an important causative role in cell death. Therefore, compounds that control the level of ROS may confer radioprotective effects. Ebselen, a seleno-organic compound, has been shown to protect against cell injury caused by ROS. The objective of this study was to examine the effects of ebselen on radiation-dependent toxicity. We investigated the protective role of ebselen against ionizing radiation in U937 cells and mice. Upon exposure to 20 Gy of gamma-irradiation, there was a distinct difference between untreated cells and the cells pretreated with 5 microM ebselen for 2 h with respect to viability, cellular redox status, and oxidative damage to cells. When cells were exposed to 2 Gy of gamma-irradiation, there was a distinct difference between the untreated cells and the cells pretreated with ebselen with respect to apoptotic features and mitochondrial function. Ebselen administration for 14 days at a daily dosage of 10 mg/kg provided substantial protection against killing and oxidative damage to mice exposed to whole-body irradiation. These data indicate that ebselen may have great potential as a new class of in vivo, non-sulfur-containing radiation protector.
Tak
Jean Kyoung
JK
School of Life Sciences and Biotechnology, College of Natural Sciences, Kyungpook National University, Taegu, Korea.
Park
Jeen-Woo
JW
D000818:Animals; D017209:Apoptosis / Q000187:drug effects / Q000502:physiology / Q000528:radiation effects; D001393:Azoles / Q000008:administration & dosage* / Q000494:pharmacology*; D019610:Cytoprotection / Q000187:drug effects / Q000528:radiation effects; D006801:Humans; D054833:Isoindoles; D051379:Mice; D008928:Mitochondria / Q000187:drug effects / Q000502:physiology / Q000528:radiation effects; D009000:Monocytes / Q000187:drug effects* / Q000473:pathology / Q000502:physiology; D016566:Organoselenium Compounds / Q000008:administration & dosage* / Q000494:pharmacology*; D010084:Oxidation-Reduction / Q000187:drug effects / Q000528:radiation effects; D018384:Oxidative Stress / Q000187:drug effects / Q000502:physiology / Q000528:radiation effects; D011833:Radiation Injuries, Experimental / Q000209:etiology / Q000517:prevention & control*; D011839:Radiation, Ionizing; D017382:Reactive Oxygen Species / Q000037:antagonists & inhibitors*; D020298:U937 Cells; D014916:Whole-Body Irradiation / Q000009:adverse effects
D001393:Azoles; D054833:Isoindoles; D016566:Organoselenium Compounds; D017382:Reactive Oxygen Species; C042986:ebselen